Phillips' Milk of Magnesia is used for symptomatic relief across two main gastrointestinal domains, generally applied when short-term symptomatic assistance is needed.

Relief of Occasional Constipation

This product is relevant for managing occasional constipation, which is characterized by infrequent or difficult bowel movements that may appear suddenly and create noticeable physiological strain. It is commonly used for managing these symptoms, where the primary benefit is that it contributes to easing the overall symptom load and supports general well-being during symptomatic phases.

“The medication helps address symptom clusters related to physical discomfort that can interfere with daily functioning.”

---

Managing Heartburn and Indigestion

It is also applicable in situations involving acid-related symptoms, which manifest as symptom clusters like burning sensations in the chest or throat, and general stomach discomfort. The use in this area is relevant for easing distress associated with episodic or fluctuating symptom patterns. It provides supportive relief when symptoms interfere with routine activities.

Quick Fact: Relevant for Managing Occasional Constipation and Acid-Related Symptoms

Regulatory References

1. NIH MedlinePlus overview on Magnesium Hydroxide

Who Can and Cannot Use Phillips' Magnesium?

Population eligibility for Phillips' Magnesium (Magnesium Hydroxide) is defined by official regulatory labeling, primarily focusing on age, organ function, and pre-existing conditions.

Contraindications and Restrictions

Use is contraindicated for individuals with a known allergy or hypersensitivity to the product or any of its ingredients. Patients with severe renal impairment or kidney disease are also generally contraindicated or required to seek mandatory professional consultation, due to the significant risk of magnesium accumulation in the blood (hypermagnesemia).

Age Group	Eligibility Status
Adults and Children 12+	Approved for unsupervised use as both an antacid and laxative.
Children 6 to 11 years	Approved for unsupervised use as a laxative.
Children Under 6 years	Use for any purpose requires consultation with a health professional.

Conditional Use Requirements

The label specifies populations who must ask a health professional before use.

This mandatory consultation applies to pregnant or breast-feeding individuals. It also applies to patients experiencing conditions like stomach pain, nausea, or vomiting, or those with a sudden change in bowel habits lasting over 14 days. Individuals on a magnesium-restricted diet are also required to consult a doctor before use.

The official regulatory profile for Phillips' Magnesium (Magnesium Hydroxide) identifies several clinically significant interaction patterns, predominantly based on pharmacokinetic interference. The medicine can significantly reduce the systemic exposure of numerous co-administered prescription drugs due to its binding action in the gastrointestinal tract. This mechanism of reduced absorption is documented to affect the plasma concentration of entire medicinal classes, including Tetracycline antibiotics, Quinolone antibiotics, Bisphosphonates, and compounds such as Iron Salts and Ketoconazole.

To mitigate this effect, official labeling mandates a timing separation rule for administration. This restriction requires the product to be taken 2 or more hours before or after other drugs to minimize the absorption interference.

A separate interaction type involves altered clearance where the alkalinizing effect of Magnesium Hydroxide on urine is officially documented to increase the renal excretion of substances such as Salicylates, potentially reducing their therapeutic plasma concentration.

A critical population-specific constraint exists for patients with renal impairment or kidney disease. Since magnesium is eliminated by the kidneys, reduced renal clearance in these populations leads to an officially documented increased risk of hypermagnesemia (excess serum magnesium). Due to this heightened risk, the product is often designated as contraindicated in patients with renal failure unless under close medical supervision.

Osmotic Fluid Dynamics and Fecal Hydration

The primary mechanism of action involves the magnesium ion ( Mg^2+) acting as an osmotic agent in the intestinal lumen. Since Mg^2+ is poorly absorbed, its high luminal concentration creates a concentration gradient. This gradient induces osmosis, drawing and retaining water from the surrounding tissues into the bowel lumen, resulting in increased hydration and volume of the fecal mass.

---

Peristaltic Stimulation via Intraluminal Volume

This increased intraluminal volume causes a physical distension and stretching of the colonic wall. This stretching directly stimulates mechanoreceptors in the gut, thereby triggering the peristaltic reflex which enhances propulsive motility. This cascade leads to the observable physiological effect of a bowel evacuation.

---

Electrolyte Modulation and Acid Neutralization

Secondary actions include the unreacted magnesium hydroxide acting as a weak base in the stomach, neutralizing hydrochloric acid ( HCl). A small fraction of absorbed Mg^2+ systemically acts as a cofactor for metabolic enzymes and modulates Ca^2+ channel activity, which contributes to generalized smooth muscle decreased contractile activity.

Official Administration Guidelines

Phillips' Magnesium (magnesium hydroxide) is administered via the oral route as a liquid suspension or chewable tablet. The product is typically used as needed for occasional constipation, with administration instructions clearly defined by product labeling.

Dosage and Preparation

Age Group	Laxative Dose (Liquid Suspension)	Special Instruction
Adults and Children 12+	30 mL to 60 mL	Do not exceed maximum dose in 24 hours.
Children 6 to 11 years	15 mL to 30 mL	Ask a doctor for children under 6 years.

For the liquid suspension, the bottle must be shaken well before each use. The correct dose should be measured using the provided dosing device to ensure accuracy.

Procedural Steps

1. Shake the liquid suspension bottle well before measuring the dose.
2. Measure the appropriate volume (mL) according to the age-specific instructions above.
3. Take the dose orally once a day, or in divided doses, with a strong preference for administration at bedtime.
4. Follow each dose by drinking a full glass (8 ounces) of liquid, such as water.

If the product is in chewable form, the tablet must be chewed thoroughly before swallowing and followed by a full glass of liquid. This product is not intended for regular, long-term use; do not use for more than one week without consulting a health professional.

Research Evidence / Overview of Studies for Phillips' Magnesium

Evidence for Use in Occasional Constipation

This section will summarize the available evidence for its use as a saline laxative, detailing the types of studies (such as randomized controlled trials and comparative studies) and the functional outcomes (like spontaneous bowel movement frequency) that researchers have formally evaluated.

Research was studied for conditions characterized by functional limitations, such as occasional or chronic constipation. Studies mainly examined outcomes related to systemic or functional imbalance, such as the frequency of spontaneous bowel movements, changes in stool consistency, and the time it takes for intestinal transit. Findings describe patterns observed in the studies related to outcomes reflecting daily functioning over the observed period. The evidence contributes to understanding symptom patterns and was assigned an evidence level of moderate.

Evidence for Use in Heartburn and Indigestion

This section will review the foundational regulatory evidence and pharmacological studies that characterize its function as an antacid, focusing on the acute pH and symptom relief outcomes measured in research settings.

The antacid use of this medicine is described by its long-standing classification within regulatory monographs and historical pharmacological research. Research examined objective changes in gastric pH profiles and studies monitored patient-reported outcomes describing perceived discomfort related to acid-related symptoms. Data supporting this use is heavily based on its regulatory classification, and this evidence contributes to the broader evidence landscape for acute, episodic relief.

Long-Term Follow-up and Durability Data

Research highlights that long-term effects are not fully established, particularly concerning the patterns of response over extended use for conditions marked by functional limitations. Most key clinical trials involving magnesium-based laxatives focus on relatively short-term symptom changes, with follow-up durations limited to approximately four weeks. The available evidence provides insight into short-term changes, but the findings do not extend to understanding the sustained response or durability over many months or years.

Gaps in the Research Evidence

There is limited information for long-term outcomes for both applications. Comparative evidence is lacking for direct head-to-head trials against all newer over-the-counter laxative agents. For the antacid application, a lack of contemporary RCTs for the single-ingredient formulation means that many reported outcomes are based on combination products, leaving subgroup findings uncertain for the isolated effect of the active ingredient.

Key Studies & References Magnesium Hydroxide: MedlinePlus Drug Information

Common questions about Phillips' Magnesium (FAQ)

Q: How quickly should I expect Phillips' Magnesium to start working for constipation?

According to official product labeling, the laxative effect of Phillips' Magnesium is generally expected to result in a bowel movement within a timeframe of 30 minutes to 6 hours after the product is taken. This range reflects the variable response time based on individual body processes.

Q: Does taking Phillips' Magnesium affect how other oral medicines are absorbed?

Yes, official documentation describes that this product may potentially interfere with how certain prescription medicines are absorbed. This is due to the product's action in the gastrointestinal tract. For this reason, regulatory labeling often mandates a timing separation rule, indicating the product must be taken a few hours before or after other medicines to reduce the chance of absorption interference.

Q: Are there any specific foods or drinks to avoid when using Phillips' Magnesium?

Regulatory guidance requires drinking a full glass of liquid (8 ounces) with each laxative dose. Regulatory materials do not typically list specific foods or common drinks to actively avoid, but they do advise individuals who are on a magnesium-restricted diet to first consult a health professional before using this product.

Q: Is it possible to become dependent on Phillips' Magnesium over time?

Regulatory warnings indicate that prolonged use of laxatives can potentially cause dependence and other serious side effects. The product is labeled for short-term, temporary use. For this reason, the product’s label carries a time limitation, indicating it should not be used for more than one week.

Q: Is the effectiveness of Phillips' Magnesium supported by scientific studies?

Regulatory documents classify this product as a saline laxative and antacid. This classification is based on foundational regulatory evidence and pharmacological studies that have examined its effects in the body. The evidence contributes to understanding symptom patterns over short-term periods.

Q: Is Phillips' Magnesium a mineral supplement or a medicine?

Official regulatory documents describe this product as an Over-The-Counter (OTC) pharmaceutical preparation because of its dual action as a Saline Laxative and Antacid. While its active ingredient is an inorganic mineral compound, its regulated purpose is to treat specific symptoms, reflecting its classification as a medicine.

Q: Is Phillips' Magnesium the same as Milk of Magnesia?

Yes, Milk of Magnesia is the conventional or common name often used to describe the Magnesium Hydroxide Oral Suspension product. Official product information, such as on DailyMed, references this common name in relation to the medicine.

Q: Does Phillips' Magnesium contain actual elemental magnesium?

The active ingredient is the compound Magnesium Hydroxide. Regulatory labeling and product information describe the amount of magnesium (the element) contained within each dose of the medicine.

Q: Can Phillips' Magnesium be used for ongoing, daily digestive issues?

Regulatory labeling specifies that the product is indicated solely for occasional constipation and its use should not extend beyond one week. Official documents require consulting a health professional if a change in bowel habits persists over 14 days.

Q: Is it normal to experience mild stomach cramps after taking Phillips' Magnesium?

The official safety profile lists abdominal pain and colic as common adverse reactions. These terms, consistent with its function as a saline laxative, are the descriptions provided in regulatory documents.

Q: Are there different types or formulations of Phillips' Magnesium available?

Regulatory documents describe the product in several available dosage forms. These commonly include the Oral Suspension (liquid) and the Chewable Tablet form.

Q: Can Phillips' Magnesium cause dehydration?

The product works by drawing water into the colon to soften stool, and excessive use can result in fluid loss. The official safety profile links symptoms of severe overuse or overdose to issues like dry mouth, which is consistent with dehydration.

Q: What is the difference between Phillips' Magnesium and magnesium citrate?

The main difference is the active ingredient: Phillips' Magnesium contains Magnesium Hydroxide, whereas magnesium citrate is a different chemical compound. Both are classified by regulators as saline laxatives, but they each have their own specific official labeling.

Q: Is Phillips' Magnesium safe for older adults or seniors to use?

The official eligibility status includes all individuals 12 years of age and over. However, since patients with kidney impairment are at heightened risk of magnesium accumulation, specific, separate warnings for the senior population are generally not detailed on the main OTC label.

Q: Can Phillips' Magnesium be taken during pregnancy according to official sources?

Official product labeling contains a dedicated warning that if a patient is pregnant or breast-feeding, they must ask a health professional before use. The label does not permit unsupervised use during these periods.

Q: Are there any known interactions with common over-the-counter pain relievers?

Official regulatory labeling specifically documents that the alkalinizing effect of magnesium hydroxide on urine may increase the renal excretion of some substances, such as Salicylates. This process may lead to a reduced plasma concentration of these types of pain relievers, as described in regulatory documents.

Q: Are there potential interactions with herbal products or vitamins?

Official regulatory warnings require that patients who are taking any other drug, medicine, or preparation consult a health professional before use. This warning exists because of the potential for the product to interfere with the absorption of other substances taken orally.

Q: Are there any official warnings about using Phillips' Magnesium with heart conditions (descriptive eligibility question)?

While not always explicitly listed on the OTC label, magnesium is eliminated by the kidneys. Patients with certain pre-existing conditions, including severe heart issues, may need to consult a professional before use due to the potential for systemic absorption and accumulation of magnesium.

Q: Does Phillips' Magnesium interact with calcium supplements?

Regulatory materials document that the systemic effects of absorbed magnesium may potentially cause a decrease in serum calcium levels (an electrolyte). However, a direct interaction warning specifically concerning oral calcium supplements is not present on the official product label.

Q: Can Phillips' Magnesium affect lab test results?

Regulatory materials list possible effects on certain laboratory test results. These include potential changes in blood levels, such as an increase in magnesium levels and a decrease in protein and calcium levels.

Q: Can Phillips' Magnesium cause an electrolyte imbalance?

The official safety profile explicitly documents the risk of Hypermagnesemia (excess serum magnesium), which is considered a serious safety signal and an instance of electrolyte imbalance. This risk is particularly noted for patients who have compromised kidney function.

Q: Is there any difference in effectiveness between brand name and generic magnesium hydroxide?

The FDA applies the same official Drug Facts labeling requirements and regulatory standards for active ingredient concentration and product classification to both brand name products and generic magnesium hydroxide counterparts.

The storage and disposal of Phillips' Magnesium (Magnesium Hydroxide Oral Suspension) must strictly follow the requirements documented in official regulatory labeling to maintain the product’s quality and ensure public safety.

Requirement Category	Official Regulatory Statement
Storage Temperature	Store at room temperature, specifically 20^circC to 25^circC (68^circF to 77^circF).
Stability/Handling	Avoid freezing the suspension and shake well before use to ensure uniformity. Keep the container tightly closed.
Child Protection	Keep out of the reach of children to prevent accidental ingestion.
Disposal Instructions	Do not flush unused medicine down the toilet or pour it into a drain. Dispose of according to local authority requirements for pharmaceutical waste.

These official instructions define how the Oral Suspension must be protected from temperature extremes, such as freezing, which could compromise the product's physical state. Container integrity is required, and disposal procedures prevent environmental harm by mandating safe, locally compliant methods.